Clinical Trials Browser

Phase 2 × Suspended × Osteosarcoma × Clear all

NCT04616560 2026-05-13

Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma

Phase 2 Suspended

Osteosarcoma

NCT04824352 2024-05-14

AIEO

Phase 2 Suspended

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions